To clarify whether expression levels of PAI-1 and LRP1 were significantly associated with clinicopathological factors of patients with ESCC, we performed immunohistochemistry analyses of PAI-1 and LRP1 in 69 human ESCC tissues. The gene discussed is SERPINE1; the disease is esophageal squamous cell carcinoma.